Author

Miaomiao Ma

Changping Laboratory

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:deep learning· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Fanchong JianiD· 2 shared Yuanling YuiD· 2 shared Yunlong CaoiD· 2 shared Aoxiang Han· 1 shared Ayijiang YisimayiiD· 1 shared Fei ShaoiD· 1 shared Fei Shao· 1 shared Haiyan SuniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Fanchong JianORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Human monoclonal antibodies that target the SFTSV glycoprotein Gn head from four neutralizing epitope groups

Qianran Wang, Hao Li, Fanchong Jian, Aoxiang Han, Yuanni Liu, Jingyi Liu, Yuanling Yu, Jing Wang, Lingling Yu, Yanxia Wang, Haiyan Sun, Miaomiao Ma, Fei Shao, Liuluan Zhu, Wei Liu, Yunlong Cao

The paper isolates human monoclonal antibodies against SFTSV Gn, identifies four neutralizing epitope groups, and validates their neutralization through structural analysis.

Cell Reports · Apr 1, 2026Peer-reviewedImmunology

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1

Fanchong Jian, Jing Wang, Ayijiang Yisimayi, Weiliang Song, Yanli Xu, Xiaosu Chen, Xiao Niu, Sijie Yang, Yuanling Yu, Peng Wang, Haiyan Sun, Lingling Yu, Yao Wang, Ran An, Wenjing Wang, , Yunlong Cao

This study analyzes the humoral immune response to SARS-CoV-2 XBB and JN.1 lineages, showing JN.1 elicits superior neutralization and highlights the need for JN.1-based vaccine boosters.

bioRxiv · Apr 19, 2024Immunology